Lukas Pekar

508 total citations
28 papers, 366 citations indexed

About

Lukas Pekar is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Lukas Pekar has authored 28 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Radiology, Nuclear Medicine and Imaging, 13 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Lukas Pekar's work include Monoclonal and Polyclonal Antibodies Research (23 papers), CAR-T cell therapy research (10 papers) and Glycosylation and Glycoproteins Research (7 papers). Lukas Pekar is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (23 papers), CAR-T cell therapy research (10 papers) and Glycosylation and Glycoproteins Research (7 papers). Lukas Pekar collaborates with scholars based in Germany, United States and Italy. Lukas Pekar's co-authors include Stefan Zielonka, Simon Krah, Bernhard Valldorf, Lars Toleikis, Harald Kolmar, Steffen C. Hinz, Achim Doerner, Michael Hust, Andreas Evers and Giulio Russo and has published in prestigious journals such as The Journal of Immunology, Frontiers in Immunology and Protein Science.

In The Last Decade

Lukas Pekar

25 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lukas Pekar Germany 13 276 195 124 122 40 28 366
Bryan Edwards United Kingdom 8 295 1.1× 254 1.3× 71 0.6× 80 0.7× 21 0.5× 12 366
Steffen C. Hinz Germany 11 239 0.9× 229 1.2× 53 0.4× 68 0.6× 54 1.4× 15 327
Felix Unverdorben Germany 8 137 0.5× 147 0.8× 50 0.4× 72 0.6× 15 0.4× 11 240
Huifang Zong China 10 170 0.6× 155 0.8× 84 0.7× 142 1.2× 17 0.4× 19 287
Veronica Juan United States 8 163 0.6× 286 1.5× 63 0.5× 29 0.2× 18 0.5× 9 359
Stefano F. Liparoto United States 6 135 0.5× 159 0.8× 119 1.0× 42 0.3× 9 0.2× 7 279
Laura Rhiel Germany 7 292 1.1× 266 1.4× 54 0.4× 82 0.7× 64 1.6× 8 356
Joanne Compson United Kingdom 5 116 0.4× 174 0.9× 45 0.4× 56 0.5× 6 0.1× 6 244
Nishant K. Singh United States 10 139 0.5× 173 0.9× 237 1.9× 183 1.5× 16 0.4× 15 377
Emma Cummins Ireland 5 113 0.4× 130 0.7× 56 0.5× 24 0.2× 9 0.2× 6 202

Countries citing papers authored by Lukas Pekar

Since Specialization
Citations

This map shows the geographic impact of Lukas Pekar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukas Pekar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukas Pekar more than expected).

Fields of papers citing papers by Lukas Pekar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lukas Pekar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukas Pekar. The network helps show where Lukas Pekar may publish in the future.

Co-authorship network of co-authors of Lukas Pekar

This figure shows the co-authorship network connecting the top 25 collaborators of Lukas Pekar. A scholar is included among the top collaborators of Lukas Pekar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lukas Pekar. Lukas Pekar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pekar, Lukas, et al.. (2026). Multifunctional antibody-derived IL-12 mimetics: prospects of future clinical development. Expert Opinion on Investigational Drugs. 35(1). 1–8.
2.
Natale, Veronica, et al.. (2025). Trispecific SEED antibodies engineered for neutrophil-mediated cell killing. mAbs. 17(1). 2532851–2532851. 1 indexed citations
3.
Becker, Stefan, Jürgen Rödel, Jürgen Scheller, et al.. (2025). Taming interleukin‐12: Engineering of bispecific antibody‐based IL‐12 mimetics with biased agonism capacities. Protein Science. 34(3). e70072–e70072. 4 indexed citations
4.
5.
Pekar, Lukas, et al.. (2024). A platform for the early selection of non-competitive antibody-fragments from yeast surface display libraries. Biological Chemistry. 405(11-12). 765–775. 5 indexed citations
6.
Wang, Qun, Sireesha Yalavarthi, Lukas Pekar, et al.. (2024). Development of a c-MET x CD137 bispecific antibody for targeted immune agonism in cancer immunotherapy. Cancer Treatment and Research Communications. 39. 100805–100805. 2 indexed citations
7.
Pekar, Lukas, et al.. (2024). Discovery of potent allosteric antibodies inhibiting EGFR. mAbs. 16(1). 2406548–2406548. 4 indexed citations
8.
9.
Fernández‐Quintero, Monica L., Enrico Guarnera, Djordje Müsil, et al.. (2024). On the humanization of VHHs: Prospective case studies, experimental and computational characterization of structural determinants for functionality. Protein Science. 33(11). e5176–e5176. 11 indexed citations
10.
Valldorf, Bernhard, Andreas Evers, Simon Krah, et al.. (2024). Bovine ultralong CDR-H3 derived knob paratopes elicit potent TNF-α neutralization and enable the generation of novel adalimumab-based antibody architectures with augmented features. Biological Chemistry. 405(7-8). 461–470. 1 indexed citations
11.
Pekar, Lukas, Thomas L. Clarke, Lukas Friedrich, et al.. (2023). AI/ML combined with next-generation sequencing of VHH immune repertoires enables the rapid identification of de novo humanized and sequence-optimized single domain antibodies: a prospective case study. Frontiers in Molecular Biosciences. 10. 1249247–1249247. 15 indexed citations
12.
Krah, Simon, et al.. (2023). Isolation of Antigen-Specific Unconventional Bovine Ultra-Long CDR3H Antibodies Using Cattle Immunization in Combination with Yeast Surface Display. Methods in molecular biology. 2681. 113–129. 3 indexed citations
13.
Evers, Andreas, Lukas Pekar, Achim Doerner, et al.. (2023). Cattle-derived knob paratopes grafted onto peripheral loops of the IgG1 Fc region enable the generation of a novel symmetric bispecific antibody format. Frontiers in Immunology. 14. 1238313–1238313. 4 indexed citations
14.
Pekar, Lukas, Simon Krah, Katja Klausz, et al.. (2023). NKp46‐specific single domain antibodies enable facile engineering of various potent NK cell engager formats. Protein Science. 32(3). e4593–e4593. 19 indexed citations
15.
Bauer, Christina, Lukas Pekar, Simon Krah, et al.. (2023). Facile One-Step Generation of Camelid VHH and Avian scFv Libraries for Phage Display by Golden Gate Cloning. Methods in molecular biology. 2681. 47–60. 1 indexed citations
16.
Zielonka, Stefan, et al.. (2023). Affinity Maturation of the Natural Ligand (B7-H6) for Natural Cytotoxicity Receptor NKp30 by Yeast Surface Display. Methods in molecular biology. 2681. 231–248.
17.
Pekar, Lukas, Christian Schröter, Thomas L. Clarke, et al.. (2023). A library approach for the de novo high-throughput isolation of humanized VHH domains with favorable developability properties following camelid immunization. mAbs. 15(1). 2261149–2261149. 13 indexed citations
18.
19.
20.
Sellmann, Carolin, Lukas Pekar, Christina Bauer, et al.. (2020). A One-Step Process for the Construction of Phage Display scFv and VHH Libraries. Molecular Biotechnology. 62(4). 228–239. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bryan Edwards Breakdown of academic impact, for papers by Steffen C. Hinz Breakdown of academic impact, for papers by Felix Unverdorben Breakdown of academic impact, for papers by Huifang Zong Breakdown of academic impact, for papers by Veronica Juan Breakdown of academic impact, for papers by Stefano F. Liparoto Breakdown of academic impact, for papers by Laura Rhiel Breakdown of academic impact, for papers by Joanne Compson Breakdown of academic impact, for papers by Nishant K. Singh Breakdown of academic impact, for papers by Emma Cummins
Rankless by CCL
2026